Disrupting the binding of β-amyloid oligomers to EphB2 receptor using a small interfering peptide is neuroprotective in a mouse model of Alzheimer’s disease.
Disrupting the binding of β-amyloid oligomers to EphB2 receptor using a small interfering peptide is neuroprotective in a mouse model of Alzheimer’s disease.